CDSCO Panel Approves Eli Lilly's Protocol Amendment proposal to study Antidiabetic Drug Tirzepatide Dr. Divya Colin4 Aug 2024 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the protocol...
Head-to-Head Diabetes Drugs for Weight Loss: Tirzepatide Outperforms Semaglutide in New Study Medha Baranwal18 July 2024 9:00 AM ISTUSA: Two pharmaceutical contenders, semaglutide and tirzepatide, have emerged as promising options in combating overweight and obesity. Recent studies...
Eli Lilly Company Gets CDSCO Panel Nod To Import, Market Antidiabetic drug Tirzepatide for chronic weight management Dr. Divya Colin3 July 2024 6:00 PM ISTNew Delhi: The drug major Eli Lily Company India has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Tirzepatide Therapymay significantly Reduce Effects of Obstructive Sleep Apnea in Obese Patients: NEJM Jacinthlyn Sylvia30 Jun 2024 8:00 PM ISTA recent study published in the New England Journal of Medicine suggests that tirzepatide which is primarily used to treat type 2 diabetes, may...
Use of Tirzepatide Shown to Improve Sleep Apnea and Cardiovascular Outcomes: ADA meeting Dr. Kamal Kant Kohli29 Jun 2024 3:30 AM ISTToday, findings from the SURMOUNT-OSA, a study of tirzepatide in patients with obstructive sleep apnea (OSA) and obesity, were announced, revealing...
WHO, Eli Lilly warn against fake versions of popular weight loss, diabetes drugs Ruchika Sharma22 Jun 2024 4:46 PM ISTGeneva: The World Health Organization (WHO) and pharmaceutical company Eli Lilly and Co. are cautioning the public about fake versions of popular...
Switching to tirzepatide from GLP-1 RAs shows promise in diabetes treatment, unravels study Medha Baranwal12 Jun 2024 10:00 AM ISTUSA: In the realm of diabetes management, a significant shift is underway with the emergence of tirzepatide as a potential game-changer. A recent...
Breakthrough in Obesity Treatment: Tirzepatide Shows Promise in Chinese Adults - SURMOUNT-CN Trial Medha Baranwal3 Jun 2024 10:00 AM ISTChina: In the relentless battle against obesity, a new contender has emerged: tirzepatide. The results of the SURMOUNT-CN randomized clinical trial...
Persistence with tirzepatide key to effective weight loss, study suggests Medha Baranwal15 May 2024 10:00 AM ISTUSA: In the ever-evolving landscape of diabetes management, promising new findings suggest that persistence with tirzepatide-a novel investigational...
Tirzepatide effectively provides good glycaemic control in diabetes patients undergoing hemodialysis: Study Dr. Shravani Dali13 May 2024 9:45 AM ISTTirzepatide effectively provides good glycaemic control in diabetes patients undergoing hemodialysis suggests a study published in the Endocrinology,...
Tirzepatide Shows Promise in Reducing Sleep Apnea Severity in Adults with Obesity: SURMOUNT-OSA Trial Medha Baranwal18 April 2024 8:45 PM ISTUSA: Tirzepatide (Zepbound), in both the 10 mg or 15 mg dose, reduces sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep...
Tirzepatide offers superior glycemic control compared with insulin, irrespective of baseline levels: Study Medha Baranwal8 April 2024 10:00 AM ISTUSA: The post hoc analyses of the SURPASS-3 and SURPASS-4 trials revealed superior glycemic control with tirzepatide compared with insulin in patients...
